In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole
- 1 March 1984
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 19 (3) , 412-416
- https://doi.org/10.1128/jcm.19.3.412-416.1984
Abstract
The MICs and minimal lethal concentrations of four antimycotics, amphotericin B, 5-fluorocytosine, miconazole nitrate, and ketoconazole, were determined for 25 yeast isolates representing species uncommonly implicated in candidiasis. A microdilution procedure was employed with complex and synthetic media. The isolates, in general, were susceptible to the same antimicrobial agents shown to be effective against Candida albicans, but differences between some of the species in relative susceptibilities to the antifungal agents were noted. Isolates of atypical sucrose-negative Candida tropicalis were similar in their susceptibility patterns to typical isolates of the species. Relative resistance to amphotericin B, miconazole nitrate, and ketoconazole was noted for two Candida lusitaniae isolates, but all strains were susceptible to 5-fluorocytosine. Candida norvegensis isolates were more resistant to miconazole and ketoconazole than C. albicans clinical isolates. The microtiter system was satisfactory for determining minimal inhibitory concentrations, but the system is not recommended for detecting finite differences in drug susceptibilities or for detecting drug synergism.This publication has 13 references indexed in Scilit:
- Primary site of action of ketoconazole on Candida albicansAntimicrobial Agents and Chemotherapy, 1982
- The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium.1981
- In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesisAntimicrobial Agents and Chemotherapy, 1980
- In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patientsAntimicrobial Agents and Chemotherapy, 1980
- Candida tropicalis: A Major Pathogen in Immunocompromised PatientsAnnals of Internal Medicine, 1979
- Assay for Yeast Susceptibility to 5-Fluorocytosine and Amphotericin B in a Frozen Microtiter SystemAmerican Journal of Clinical Pathology, 1979
- Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a HumanAntimicrobial Agents and Chemotherapy, 1979
- Sucrose-negative variants of Candida tropicalisJournal of Clinical Microbiology, 1977
- Effect of Culture Media on the Antifungal Activity of Miconazole and Amphotericin B Methyl EsterThe Journal of Infectious Diseases, 1976
- The action of miconazole on the growth ofCandida albicansMedical Mycology, 1975